ESKETAMINE HYDROCHLORIDE NASAL SPRAY (Spravato®)
Clinical Indication
In combination with a SSRI or SNRI for adults with treatment-resistant Major Depressive Disorder
Comments
Administration in specialist clinic only
Date of classification
June 2020
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.